Basile Edward M 4
4 · TransMedics Group, Inc. · Filed Aug 5, 2025
Insider Transaction Report
Form 4
Basile Edward M
Director
Transactions
- Sale
Common Stock
2025-08-04$125.51/sh−4,143$519,988→ 2,866 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-04−4,143→ 4,142 totalExercise: $0.70Exp: 2026-02-16→ Common Stock (4,143 underlying) - Exercise/Conversion
Common Stock
2025-08-04$0.70/sh+4,143$2,900→ 7,009 total
Footnotes (2)
- [F1]The option is fully vested.
- [F2]The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.